LDT600 (Telbivudine)
CLDT600A2104
Phase 1 small_molecule completed
Quick answer
LDT600 (Telbivudine) for Chronic Hepatitis B is a Phase 1 program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Chronic Hepatitis B
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed